Feedback / Questions
ALE.P02 - Alentis Therap
https://www.oncnursingnews.com/view/fda-fast-tracks-ale-p02-for-cldn1-poisitive-solid-cancers
Tony S K Mok; Luigi Manenti
Nov 20, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next